Lifesprout

company

About

LifeSprout offers revolutionary products for soft tissue replacement and regeneration

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
$500K
Industries
Biotechnology,Emergency Medicine,Health Care,Medical
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

LifeSprout is developing the next generation of synthetic soft tissue substitutes for aesthetic and reconstructive medicine. They offer revolutionary products for aesthetic and regenerative medicine. They have created a platform that looks and behaves like the body’s own tissues. The company is turning this into a suite of products for millions of patients each year with soft tissue losses from aging, cancer, and metabolic disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$7.30M
Lifesprout has raised a total of $7.30M in funding over 2 rounds. Their latest funding was raised on Jun 18, 2018 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 18, 2018 Seed $6.50M 1 TEDCO Detail
Mar 21, 2018 Seed $500K 1 TEDCO Detail
Sep 1, 2017 Grant $300K 1 Maryland Stem Cell Research Fund (MSCRF) Detail

Investors

Number of Lead Investors
Number of Investors
3
2
Lifesprout is funded by 2 investors. TEDCO and Maryland Stem Cell Research Fund (MSCRF) are the most recent investors.
Investor Name Lead Investor Funding Round
TEDCO Yes Seed
Maryland Stem Cell Research Fund (MSCRF) Yes Grant